A
Algernon Pharmaceuticals Inc
CNSX:AGN
Algernon Pharmaceuticals Inc
CNSX:AGN
Price:
0.055
CAD
10%
Market Closed
Market Cap:
CA$2.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Algernon Pharmaceuticals Inc
CNSX:AGN
|
CA |
|
BRF SA
NYSE:BRFS
|
BR |
|
A
|
Acroud AB
STO:ACROUD
|
SE |
|
C
|
Coastalsouth Bancshares Inc
OTC:COSO
|
US |
|
K
|
Kyowa Leather Cloth Co Ltd
TSE:3553
|
JP |
|
J
|
Jiangsu New Energy Development Co Ltd
SSE:603693
|
CN |
|
Hengtai Securities Co Ltd
HKEX:1476
|
CN |
|
Just Dial Ltd
NSE:JUSTDIAL
|
IN |
|
Dynagas LNG Partners LP
NYSE:DLNG
|
MC |
|
G
|
Gopeng Bhd
KLSE:GOPENG
|
MY |
|
Indigo Books and Music Inc
TSX:IDG
|
CA |
|
Tempur Sealy International Inc
NYSE:TPX
|
US |
Balance Sheet
Balance Sheet Decomposition
Algernon Pharmaceuticals Inc
Algernon Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Algernon Pharmaceuticals Inc
Algernon Pharmaceuticals Inc
Balance Sheet
Algernon Pharmaceuticals Inc
Algernon Pharmaceuticals Inc
Currency: CAD
| Aug-2015 | Aug-2016 | Aug-2017 | Aug-2018 | Aug-2019 | Aug-2020 | Aug-2021 | Aug-2022 | Aug-2023 | Aug-2024 | Aug-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
1
|
2
|
1
|
1
|
0
|
6
|
2
|
1
|
0
|
1
|
0
|
|
| Cash Equivalents |
1
|
2
|
1
|
1
|
0
|
6
|
2
|
1
|
0
|
1
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
2
|
1
|
1
|
0
|
8
|
5
|
3
|
0
|
1
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
1
|
0
|
0
|
5
|
5
|
5
|
5
|
4
|
3
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
2
+62%
|
2
-28%
|
1
-13%
|
5
+275%
|
13
+140%
|
10
-21%
|
8
-20%
|
4
-48%
|
4
-6%
|
5
+24%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-13%
|
0
-68%
|
0
+19%
|
0
+541%
|
1
+66%
|
1
+68%
|
3
+146%
|
3
+8%
|
2
-35%
|
2
+23%
|
|
| Equity | ||||||||||||
| Common Stock |
2
|
7
|
8
|
9
|
13
|
21
|
26
|
27
|
28
|
30
|
30
|
|
| Retained Earnings |
0
|
5
|
7
|
7
|
8
|
9
|
17
|
21
|
27
|
27
|
29
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
+73%
|
2
-25%
|
1
-14%
|
5
+264%
|
12
+146%
|
9
-25%
|
6
-38%
|
1
-74%
|
2
+47%
|
3
+24%
|
|
| Total Liabilities & Equity |
1
N/A
|
2
+62%
|
2
-28%
|
1
-13%
|
5
+275%
|
13
+140%
|
10
-21%
|
8
-20%
|
4
-48%
|
4
-6%
|
5
+24%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
20
|
0
|
1
|
1
|
2
|
6
|
7
|
9
|
16
|
27
|
34
|
|
Switch to:
Switch to:
See Also
Discover More
